Win over one internal champion to break committee resistance
In Solomon Asch's classic conformity experiments, individuals agreed with an obviously incorrect group consensus on roughly a third of trials. However, introducing just a single dissenting partner who voiced the right answer caused conformity rates to plummet by over seventy-five percent. In enterprise sales, winning over an entire buying committee at once is unrealistic. Securing one internal champion breaks the group's united front, granting silent skeptics social permission to support your pitch.
The Illusion of Certainty in Asch's Experiments
In the 1950s, psychologist Solomon Asch designed a series of laboratory experiments to measure how social pressure from a majority could cause a person to conform. The setup was deceptively simple. A college student was invited into a room alongside several peers for what was billed as a study on visual perception. In reality, all the other participants were confederates—actors working with the experimenter—and the true subject was seated so that they responded near the end of the group.
The task required participants to look at a display showing a target line and three comparison lines of visibly differing lengths, labeled A, B, and C. The objective answer was unmistakable: one line was identical in length to the target line, while the other two differed noticeably. Under normal circumstances, when individuals performed the task in isolation without any peers present, they made virtually no errors, answering correctly more than ninety-nine percent of the time.
The experiment shifted during the critical trials. On these predetermined rounds, every confederate systematically and unanimously announced the same clearly wrong comparison line as the match. The genuine subject was faced with a stark dilemma: trust their own clear visual perception or bend to the unanimous consensus of the group. Rather than remaining steadfast, subjects conformed to the group's incorrect assessment roughly one-third of the time across all trials, and approximately seventy-five percent of participants yielded to the majority on at least one critical trial.